Case report

Dramatic response to alectinib in a lung cancer patient with a novel VKORC1L1-ALK fusion and an acquired ALK T1151K mutation

Zhu VW, Schrock AB, Bosemani T, Benn BS, Ali SM, Ou SI

Lung Cancer: Targets and Therapy 2018, 9:111-116

Published Date: 8 November 2018